Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Wednesday, Synergy Pharmaceuticals Inc (NASDAQ:SGYP)'s Chairman, Gabriel Cerrone, made a $317,250 purchase of SGYP, buying 87,820 shares at a cost of $3.61 each. Cerrone was up about 16.8% on the purchase at the high point of today's trading session, with SGYP trading as high as $4.22 at last check today. Synergy Pharmaceuticals Inc is trading up about 10.4% on the day Thursday. This buy marks the first one filed by Cerrone in the past twelve months.
And on Tuesday, CEO John A. Crum bought $267,650 worth of Midstates Petroleum Co Inc (AMEX:MPO), buying 50,000 shares at a cost of $5.35 a piece. Before this latest buy, Crum bought MPO on 3 other occasions during the past twelve months, for a total investment of $589,638 at an average of $7.86 per share. Midstates Petroleum Co Inc is trading up about 3.9% on the day Thursday. Investors can buy MPO even cheaper than Crum did, with shares trading as low as $4.90 at last check today -- that's 8.5% below Crum's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.